Companies / BOC Sciences / Veltuzumab
BOC Sciences

Veltuzumab | BOC Sciences

Veltuzumab is a humanized anti-CD20 monoclonal antibody. Veltuzumab has been investigated for the treatment of non-Hodgkin's lymphoma.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.